Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function
Código 2925 (Harmonized System 2012 by 4 digits)
2023: US$53.1M, Total Trade Exchange
2023: US$4.11M, International Sales
2023: US$49M, International Purchases
Código 2925 (Harmonized System 2012 by 4 digits)
2023: US$53.1M, Total Trade Exchange
2023: US$4.11M, International Sales
2023: US$49M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function was US$53.1M.
In 2023, the states with the most international sales in Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were Estado de México (US$2.27M) and Ciudad de México (US$327k).
The states with the most international purchases in 2023 were Jalisco (US$15M), Ciudad de México (US$14.7M), Estado de México (US$10.7M), Guanajuato (US$5.02M), and Querétaro (US$928k).
In 2023, the main commercial destinations of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were Brazil (US$2.02M), United Kingdom (US$322k), Bangladesh (US$92.5k), Guatemala (US$75k), and United States (US$39.7k).
The main commercial origins of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function in 2023 were China (US$20.8M), South Korea (US$5.74M), France (US$5.52M), Norway (US$5.08M), and India (US$4.06M).
In the global context, the main exporting countries of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function in 2022 were China (US$918M), France (US$352M), and India (US$278M). In the same year, the main importing countries of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were United States (US$396M), China (US$306M), and Brazil (US$174M).
US$53.1M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function in Mexico (including international purchases and sales) was US$53.1M.
The visualizations show the net balance of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024
In November 2024, international sales of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were US$128k, while international purchases reached US$7.65M. The above results in a trade balance of -US$7.52M.
2024-Q4: US$17.6k, International Sales
The visualization shows the quarterly concentration of international sales of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function at state level.
In the fourth quarter of 2024, international sales were US$17.6k, being the states with the most sales Estado de México (US$17.6k).
Estado de México: US$2.27M, State with the Most International Sales (2023)
Brazil: US$2.02M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were Estado de México (US$2.27M) and Ciudad de México (US$327k).
In 2023, the countries with the most international purchases from Mexico were Brazil (US$2.02M), United Kingdom (US$322k), Bangladesh (US$92.5k), Guatemala (US$75k), and United States (US$39.7k).
Jalisco: US$15M, State with the Most International Purchases (2023)
China: US$20.8M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were Jalisco (US$15M), Ciudad de México (US$14.7M), Estado de México (US$10.7M), Guanajuato (US$5.02M), and Querétaro (US$928k).
The countries with the most international sales to Mexico in 2023 were China (US$20.8M), South Korea (US$5.74M), France (US$5.52M), Norway (US$5.08M), and India (US$4.06M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were China (US$918M), France (US$352M), and India (US$278M). In the same year, the main importing countries for Carboxyimide-Function Compounds (Including Saccharin and its Salts) and Imine Function were United States (US$396M), China (US$306M), and Brazil (US$174M).